UNITY BIOTECHNOLOGY INC's ticker is and the CUSIP is 91381U200. A total of 42 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 49,172 | $118,013 | 14.70% |
| ARCH Venture Management, LLC | 1,004,817 | $2,411,561 | 1.57% |
| Mayo Clinic | 124,081 | $297,794 | 0.57% |
| Alyeska Investment Group, L.P. | 1,286,000 | $3,086,400 | 0.02% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 179,080 | $429,792 | 0.01% |
| Cercano Management LLC | 41,238 | $98,971 | 0.00% |
| Johnson Midwest Financial, LLC | 661 | $1,586 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $120,000 | 0.00% |
| Alyeska Investment Group, L.P. | 38,695 | $92,868 | 0.00% |
| Laurion Capital Management LP | 70,000 | $168,000 | 0.00% |